Completed PHASE2 INTERVENTIONAL NCT00000603

Cord Blood Stem Cell Transplantation Study (COBLT)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Anemia, Aplastic Fanconi Anemia Hematologic Diseases Hematopoietic Stem Cell Transplantation Leukemia Myelodysplastic Syndromes Neoplasms Severe Combined Immunodeficiency

Interventions stem cell transplantation

Updated 5 times since 2017 Last updated: Apr 12, 2016 Started: Sep 30, 1996 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Anemia, Aplastic and Fanconi Anemia and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 5 recorded versions since 1996 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.